Ondansetron Treatment for Alcoholism

Completed · Phase 2

Conditions studied: Alcoholism

In brief

The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.

Key facts

Study ID

NCT00000443

Run by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Expected to finish

2000-04-01

Last updated by the study team

2005-06-24

Who can join

Age: 25 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet criteria for alcohol dependence.
• Subjects with early onset alcoholism must also have a diagnosis of antisocial personality disorder.
• Understand the requirements of the study and be able to complete the questionnaires and rating scales.

You may not qualify if…

• Current diagnosis of substance dependence or self-report of having used narcotics (opiates, cocaine, amphetamine-like substances, and hallucinogens) in the 30 day period prior to study.
• Positive urine drug screen test for narcotics, barbiturates, or benzodiazepines.
• Receiving current psychotropic medications.
• Current history of other psychiatric disorders excluding nicotine dependence.
• Hepatocellular disease.
• Pregnant females.

Where it is running

• Substance Abuse Research Center, University of Texas Health Science Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.